AR068419A1 - Cepas de mycoplasma atenuadas vivas - Google Patents

Cepas de mycoplasma atenuadas vivas

Info

Publication number
AR068419A1
AR068419A1 ARP080103957A ARP080103957A AR068419A1 AR 068419 A1 AR068419 A1 AR 068419A1 AR P080103957 A ARP080103957 A AR P080103957A AR P080103957 A ARP080103957 A AR P080103957A AR 068419 A1 AR068419 A1 AR 068419A1
Authority
AR
Argentina
Prior art keywords
live
mycoplasma bacteria
atenuated
mycoplasma
lives
Prior art date
Application number
ARP080103957A
Other languages
English (en)
Inventor
Mahesh Kumar
Muhammad Ayub Khan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR068419A1 publication Critical patent/AR068419A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente proporciona bacteria Mycoplasma atenuada, viva que exhibe expresion reducida de una o más proteínas seleccionadas del grupo que consiste de piruvato deshidrogenasa, fosfopiruvato hidratasa, 2-desoxirribosa-5-fosfato aldolasa, y proteína L35 ribosomica, relacionada con una bacteria Mycoplasma tipo silvestre de la misma especie. También se proporcionan vacunas y métodos de vacunacion que involucran el uso de la bacteria Mycoplasma atenuada, viva, y métodos para hacer bacteria Mycoplasma atenuada viva.
ARP080103957A 2007-09-11 2008-09-11 Cepas de mycoplasma atenuadas vivas AR068419A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99345607P 2007-09-11 2007-09-11

Publications (1)

Publication Number Publication Date
AR068419A1 true AR068419A1 (es) 2009-11-18

Family

ID=40019605

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103957A AR068419A1 (es) 2007-09-11 2008-09-11 Cepas de mycoplasma atenuadas vivas

Country Status (16)

Country Link
US (2) US20090068231A1 (es)
EP (1) EP2209489A1 (es)
JP (1) JP2012501624A (es)
KR (1) KR20100072019A (es)
CN (1) CN101820902A (es)
AR (1) AR068419A1 (es)
AU (1) AU2008298749A1 (es)
BR (1) BRPI0816686A2 (es)
CA (1) CA2699367A1 (es)
CL (1) CL2008002709A1 (es)
CO (1) CO6270237A2 (es)
MX (1) MX2010002867A (es)
RU (1) RU2473682C2 (es)
TW (1) TW200920397A (es)
WO (1) WO2009036241A1 (es)
ZA (1) ZA201002515B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
EP2362780B1 (en) 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
EA201291175A1 (ru) * 2010-05-19 2013-06-28 Байопропертис Пти Лтд. Способы, относящиеся к аттенуированной микоплазме
EA038206B1 (ru) 2012-12-28 2021-07-23 Бёрингер Ингельхайм Ветмедика Гмбх Иммуногенная композиция, содержащая антигены микоплазм
CN104968365B (zh) 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
WO2015109578A1 (zh) * 2014-01-26 2015-07-30 江苏省农业科学院 一种猪支原体肺炎减毒活疫苗及其应用
HRP20221440T1 (hr) 2015-08-14 2023-02-03 Zoetis Services Llc Pripravci bakterije mycoplasma bovis
RU2724549C1 (ru) * 2016-08-09 2020-06-23 Эгрикалчурал Текнолоджи Рисерч Инститьют Композиция для профилактики и лечения инфекции mycoplasma hyorhinis и способ получения указанной композиции
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
CN111172083A (zh) * 2020-03-06 2020-05-19 北京龙科方舟生物工程技术有限公司 一种用于高密度培养山羊支原体山羊肺炎亚种的培养基及其发酵培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3881993T2 (de) * 1987-09-18 1993-09-30 Akzo Nv Mycoplasma-Impfstoff.
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
CL2008002675A1 (es) * 2007-09-11 2008-11-07 Wyeth Corp Bacteria de mycoplasma gallisepticum atenuada; composicion de vacuna que la comprende; método de vacunación; y método de identificación de clones de mycoplasma gallisepticum atenuados.

Also Published As

Publication number Publication date
CO6270237A2 (es) 2011-04-20
CA2699367A1 (en) 2009-03-19
BRPI0816686A2 (pt) 2015-03-17
MX2010002867A (es) 2010-05-24
EP2209489A1 (en) 2010-07-28
US20120045476A1 (en) 2012-02-23
AU2008298749A1 (en) 2009-03-19
US20090068231A1 (en) 2009-03-12
CL2008002709A1 (es) 2008-10-24
RU2010110447A (ru) 2011-10-20
ZA201002515B (en) 2010-12-29
JP2012501624A (ja) 2012-01-26
TW200920397A (en) 2009-05-16
CN101820902A (zh) 2010-09-01
KR20100072019A (ko) 2010-06-29
WO2009036241A1 (en) 2009-03-19
RU2473682C2 (ru) 2013-01-27

Similar Documents

Publication Publication Date Title
AR068419A1 (es) Cepas de mycoplasma atenuadas vivas
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
BR112017017805A2 (pt) composição
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
EA201691478A1 (ru) Новый полисахарид и его применения
AR068418A1 (es) Bacteria mycoplasma gallisepticum atenuada, composicion de vacuna, metodos para identificar clones de mycoplasma gallisepticum atenuados y vacunar un animal contra infeccion de mycoplasma gallisepticum
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
BRPI1011934A8 (pt) Composição
BR112016006048A8 (pt) composições antimicrobianas
ES2570990T3 (es) Alimento fermentado que contiene bacterias bifidobacterium y método para producir el mismo
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
AR075484A1 (es) Pestivirus quimericos
BR112015011697A2 (pt) antibióticos macrocíclicos de amplo espectro
UY35366A (es) ?genes de toxina y métodos para su uso?.
BR112012028893A2 (pt) composições imunoestimuladoras e de vacina
CR20150310A (es) Solución para preservar conductos vasculares
MX2010000864A (es) Vacuna de celulas enteras estafilococcicas inactivadas.
BR112014014319A2 (pt) composições de cuidado oral
UY31437A1 (es) Vacuna de mycoplasma bovis y métodos de uso de la misma
AR092630A1 (es) Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas
BR112017003556A2 (pt) método de cultivo de um micro-organismo.
PE20190397A1 (es) Virus de enteritis de pato y usos del mismo
WO2018213526A3 (en) UV-RESISTANT BIOLOGICAL DEVICES AND EXTRACTS AND METHODS OF MAKING AND USING THE SAME
NZ589981A (en) Cattle vaccines comprising a disrupted M. bovis bacterium

Legal Events

Date Code Title Description
FA Abandonment or withdrawal